New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
10:40 EDTMDR, TRIP, CTRP, HZNP, OLEDOptions with decreasing implied volatility: OLED HZNP TRIP CTRP MDR
News For OLED;HZNP;TRIP;CTRP;MDR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 26, 2014
09:46 EDTCTRPCtrip.com downgraded to Neutral from Buy at UBS
08:49 EDTCTRPCtrip.com downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
07:19 EDTCTRPCtrip.com price target lowered to $64 from $74 at Brean Capital
Subscribe for More Information
07:05 EDTCTRPCtrip.com downgraded to Market Perform from Outperform at Raymond James
05:37 EDTCTRPCtrip.com price target lowered to $49 from $55 at Piper Jaffray
Piper Jaffray lowered its price target for Ctrip.com shares to $49 saying the company's Q4 margin outlook suggests increasing competitive pressure. Piper says its "unclear" when the margin pressure will ease and reiterates a Neutral rating on the stock.
November 25, 2014
17:02 EDTCTRPCtrip.com sees Q4 revenue growth approximately 30% YoY, consensus $315.3M
Subscribe for More Information
17:01 EDTCTRPCtrip.com reports Q3 adjusted EPS 36c, consensus 20c
Subscribe for More Information
November 24, 2014
09:11 EDTTRIPTripAdvisor coverage assumed with an Outperform at Credit Suisse
Subscribe for More Information
November 21, 2014
16:34 EDTCTRPRoyal Caribbean, Ctrip.com announce joint venture through SkySea Cruises
Subscribe for More Information
06:17 EDTCTRPCtrip.com initiated with an Overweight at HSBC
Subscribe for More Information
November 18, 2014
16:12 EDTHZNPHorizon Pharma reports positive effect of RAYOS in reducing joint stiffness
Subscribe for More Information
November 17, 2014
07:50 EDTTRIPTripAdvisor price target lowered to $90 from $99 at Oppenheimer
Subscribe for More Information
November 14, 2014
10:00 EDTOLEDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:06 EDTHZNPHorizon Pharma 11.66M share Secondary priced at $12.05
Subscribe for More Information
06:42 EDTOLEDUniversal Display downgraded to Perform from Outperform at Oppenheimer
Oppenheimer downgraded Universal Display to Perform on expectations growth will slow in 2015.
November 13, 2014
14:56 EDTHZNPHorizon Pharma says Watson Labs filed ANDA for generic PENNSAID
Subscribe for More Information
10:44 EDTOLEDOptions with decreasing implied volatility
Subscribe for More Information
09:54 EDTCTRPCtrip.com rises 3.7% to $58.81 amid rumor of Baidu interest
Subscribe for More Information
07:06 EDTHZNPHorizon Pharma files to sell 11.66M shares for existing holders
Horizon Pharma announced a proposed underwritten secondary offering of 11.66M of its ordinary shares held by certain of its existing shareholders. Morgan Stanley, Citigroup, Cowen and Jefferies are acting as joint book-running managers for this offering. JMP Securities is acting as financial advisor for this offering.
November 12, 2014
08:09 EDTHZNPHorizon Pharma announces favorable Markman ruling in RAYOS patent trial
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use